Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023

Rhea-AI Summary

Biofrontera, Inc. (NASDAQ:BFRI) has been invited to present at the Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference from February 21 to 24, 2023. CEO Erica Monaco and CFO Fred Leffler will represent the company, with the presentation scheduled for February 21 at 10:00 AM ET. Attendees can engage in one-on-one meetings with management during the conference. The presentation will be available for live streaming and replay. For further details, investors can reach out via email or register online.

Biofrontera specializes in dermatological products, particularly focusing on photodynamic therapy and topical antibiotics.

WOBURN, MA / ACCESSWIRE / February 15, 2023 / Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products has been invited to present at the Third Annual Winter Wonderland - Best Ideas Virtual Investor conference, which is being held virtually on February 21^st - 24^th, 2023. Biofrontera, Inc. Chief Executive Officer, Erica Monaco, and Chief Financial Officer, Fred Leffler will represent the company at the conference.

Biofrontera, Inc. is scheduled to present on Tuesday, February 21, 2023 at 10:00AM ET. Management will be available for one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay at https://www.webcaster4.com/Webcast/Page/2952/47627

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.

Investors can register here.

About the MicroCap Rodeo Winter Wonderland Best Ideas Conference
The MicroCap Rodeo is back with its Third Annual Winter Wonderland Best Ideas Conference. This conference is a virtual conference that brings you the top 37 best ideas. Qualified institutional investors recommended each of the 37 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're focused on alpha.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Biofrontera Investor Relations
ir@bfinc.com

SOURCE: Biofrontera, Inc.

View source version on accesswire.com:
https://www.accesswire.com/739381/Biofrontera-Inc-to-Present-at-Third-Annual-Winter-Wonderland-Best-Ideas-Virtual-Investor-Conference-on-February-21st-24th-2023

FAQ

When is Biofrontera's presentation at the Winter Wonderland conference?

Biofrontera, Inc. is scheduled to present on February 21, 2023, at 10:00 AM ET.

Who from Biofrontera will be presenting at the conference?

CEO Erica Monaco and CFO Fred Leffler will represent Biofrontera at the conference.

How can I watch Biofrontera's presentation?

The presentation will be webcast live and available for replay on the conference website.

What is the focus of Biofrontera's business?

Biofrontera specializes in commercializing dermatological products, particularly for treating skin conditions.

How can investors schedule a one-on-one meeting with Biofrontera management?

Investors can request a one-on-one meeting by emailing angie.wright@issuerdirect.com.